it's for the schizophrenia drug abillify, made by japanese drug maker atsuka. the goal there, to help make sure medicines are taken as prescribed. >> we know that for all chronic medicines non-adherence is a big issue, and we know that for patients with serious mental illness non-adherence is just as much of an issue but unfortunately for them not taking their med actually lead quickly to a dramatic health care impact. >> reporter: a key atsuka emphasizes that patients make decisions with their doctors about whether to use the dlimth pills. in the opioid study dr. edward boyer says the goal isn't surveillance. >> it's an opt-in technology that's intended to help people. it's not intended to be big brother watching you all the time. >> reporter: but gaining more insights into how these powerful medicines are used could be an important step in cushing abuse. for "on the >>> while digital pills may be one front in the fight against opio epidemics, another one is treating the addiction as a disease. gary mandel is the founder, the chairman and ceo of shatterproof.